SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 204 | -94.8% | 0.00% | – |
Q1 2022 | $35,000 | -96.3% | 3,930 | -93.3% | 0.00% | – |
Q4 2021 | $940,000 | +413.7% | 58,742 | +489.5% | 0.00% | – |
Q3 2021 | $183,000 | +137.7% | 9,965 | +79.1% | 0.00% | – |
Q2 2021 | $77,000 | -75.9% | 5,564 | -74.3% | 0.00% | – |
Q1 2021 | $319,000 | +145.4% | 21,640 | +223.0% | 0.00% | – |
Q4 2020 | $130,000 | +35.4% | 6,700 | -21.7% | 0.00% | – |
Q3 2020 | $96,000 | -26.2% | 8,558 | -11.9% | 0.00% | – |
Q2 2020 | $130,000 | +282.4% | 9,709 | +124.7% | 0.00% | – |
Q1 2020 | $34,000 | -68.8% | 4,320 | -62.0% | 0.00% | – |
Q4 2019 | $109,000 | +87.9% | 11,361 | +106.3% | 0.00% | – |
Q3 2019 | $58,000 | -25.6% | 5,508 | -18.9% | 0.00% | – |
Q2 2019 | $78,000 | +136.4% | 6,789 | +164.5% | 0.00% | – |
Q1 2019 | $33,000 | +1550.0% | 2,567 | +488.8% | 0.00% | – |
Q4 2018 | $2,000 | -94.6% | 436 | -87.7% | 0.00% | – |
Q3 2018 | $37,000 | +428.6% | 3,557 | +628.9% | 0.00% | – |
Q2 2018 | $7,000 | -63.2% | 488 | -62.2% | 0.00% | – |
Q1 2018 | $19,000 | +72.7% | 1,291 | +35.0% | 0.00% | – |
Q4 2017 | $11,000 | – | 956 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
XTX Topco Ltd | 58,368 | $70,625 | 0.01% |